Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shot in the arm for cancer fighters: easier treatment tested

NCT ID NCT03656718

Completed Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

Summary

This study tested a new way to give the cancer drug nivolumab—as an injection under the skin instead of a long IV infusion. It involved 139 people with advanced cancers like lung cancer, melanoma, and kidney cancer. The main goal was to see how the body processes the drug when given this new way and to check for side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASMS BY SITE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Greenville Health System

    Greenville, South Carolina, 29605, United States

  • Local Institution - 0001

    Charlotte, North Carolina, 28204, United States

  • Local Institution - 0003

    Rozzano, MI, 20089, Italy

  • Local Institution - 0004

    Padua, 35128, Italy

  • Local Institution - 0005

    Santiago, 0, Chile

  • Local Institution - 0007

    Dallas, Texas, 75246, United States

  • Local Institution - 0009

    Beaumont, Texas, 77702-1449, United States

  • Local Institution - 0010

    Austin, Texas, 78705, United States

  • Local Institution - 0011

    Tyler, Texas, 75702, United States

  • Local Institution - 0012

    Eugene, Oregon, 97401, United States

  • Local Institution - 0014

    Dunedin, 9012, New Zealand

  • Local Institution - 0015

    Tauranga, 3112, New Zealand

  • Local Institution - 0016

    Málaga, 29010, Spain

  • Local Institution - 0017

    Madrid, 28007, Spain

  • Local Institution - 0018

    Newtown, Wellington Region, 6021, New Zealand

  • Local Institution - 0019

    Warsaw, Masovian Voivodeship, 02-781, Poland

  • Local Institution - 0020

    Detroit, Michigan, 48201-2014, United States

  • Local Institution - 0021

    Villejuif, 94805, France

  • Local Institution - 0022

    Saint-Herblain, 44805, France

  • Local Institution - 0024

    Rockville, Maryland, 20850, United States

  • Local Institution - 0025

    CABA, 1426, Argentina

  • Local Institution - 0026

    Amsterdam, North Holland, 1066 CX, Netherlands

  • Local Institution - 0031

    Liverpool, L7 8YA, United Kingdom

  • Local Institution - 0033

    Cardiff, Glamorgan, CF14 2TL, United Kingdom

  • Local Institution - 0035

    CABA, 1199, Argentina

  • Local Institution - 0037

    São Paulo, 05651-901, Brazil

  • Local Institution - 0038

    Porto Alegre, Rio Grande do Sul, 90610000, Brazil

  • Local Institution - 0039

    Maastricht, 6229 HX, Netherlands

  • Local Institution - 0040

    Rotorua, Bay of Plenty, 3046, New Zealand

  • Local Institution - 0045

    Querétaro, 76000, Mexico

  • Local Institution - 0046

    Monterrey, Nuevo León, 64710, Mexico

  • Local Institution - 0047

    Monterrey, Nuevo León, 66460, Mexico

  • Local Institution - 0048

    Mexico City, Mexico City, 14080, Mexico

  • Local Institution - 0049

    Puebla City, 72424, Mexico

  • Local Institution - 0050

    Mexico City, Mexico City, 03100, Mexico

  • Winship Cancer Institute.

    Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.

NEOPLASMS BY SITE